The Relative Strength (RS) Rating for Envista Holdings climbed into a new percentile Friday, as it got a lift from 67 to 72.
When To Sell Stocks To Lock In Profits And Minimize Losses
This unique rating identifies technical performance by using a 1 (worst) to 99 (best) score that shows how a stock's price action over the last 52 weeks compares to the rest of the market.
Over 100 years of market history reveals that the best-performing stocks often have an 80 or better RS Rating as they begin their largest runs. See if Envista Holdings can continue to rebound and clear that threshold.
Envista Holdings is working on a consolidation with a 23.00 buy point. See if the stock can break out in volume at least 40% higher than normal.
Top and bottom line growth moved higher last quarter. Earnings were up 136%, compared to -8% in the prior report. Revenue increased from -1% to 8%.
The company holds the No. 6 rank among its peers in the Medical-Systems/Equipment industry group. iRadimed, Brainsway ADR and IDEXX Laboratories are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
